Indianapolis, IN, United States of America

Gerald Gold

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerald Gold. Retrieved from https://idiyas.com/inventor/gerald-gold-e7e7khnq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Insulin Sensitivity: The Contributions of Gerald Gold

Introduction: Gerald Gold, an inventor based in Indianapolis, IN, has made significant strides in the field of biotechnology. With a focus on improving insulin sensitivity, his work has the potential to impact the lives of many individuals suffering from metabolic disorders.

Latest Patents: Gerald Gold holds a patent for "Immunoassays for insulin sensitivity enhancers." This innovative patent describes methods for producing novel compounds by covalently coupling thiazolidinedione insulin sensitivity enhancers (ISEs) to proteins. These compounds are designed to produce specific antibodies, which are particularly suitable for fluorescent immunoassays, enabling the detection of both thiazolidinedione and non-thiazolidinedione ISEs in various biological contexts, including buffers and biological tissues. Furthermore, these antibodies are instrumental in high-volume screening for immunologically related novel compounds, ensuring advancements in insulin sensitivity research.

Career Highlights: Gerald’s career is marked by his association with Eli Lilly and Company, a leading pharmaceutical firm that focuses on innovations in medicine. His experience at Eli Lilly has allowed him to further develop his expertise in the biotechnology sector, especially in applications relating to diabetes and metabolic health.

Collaborations: Throughout his career, Gerald has collaborated with notable professionals in his field, including Stuart W Bright and Scott W Sage. These collaborations have been essential in advancing research and expanding the impact of his innovative work on insulin sensitivity.

Conclusion: Gerald Gold's contributions to the field of insulin sensitivity demonstrate the critical role of inventors in advancing medical science. His patented innovations not only have the potential to enhance our understanding of diabetes and related conditions but also pave the way for new therapeutic approaches that could significantly improve patient outcomes. The work of Gerald Gold serves as an inspiration within the science and medical communities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…